Kesimpta الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

kesimpta

novartis ireland ltd - ofatumumab - heila-og mænusigg, köstum tilkynnt - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Ozawade الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Methylphenidate STADA Hart hylki með breyttan losunarhraða 30 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 30 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg

Methylphenidate STADA Hart hylki með breyttan losunarhraða 20 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 20 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð; methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Medikinet CR (Medikinet retard) Hart hylki með breyttan losunarhraða 30 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medikinet cr (medikinet retard) hart hylki með breyttan losunarhraða 30 mg

medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg